Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.
第一作者:
David,Euhus
第一单位:
Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA. david.euhus@utsouthwestern.edu
作者:
主题词
腺病毒E1A蛋白质类(Adenovirus E1A Proteins);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);细胞凋亡(Apoptosis);活组织检查, 细针(Biopsy, Fine-Needle);乳房(Breast);乳腺肿瘤(Breast Neoplasms);癌, 小叶状(Carcinoma, Lobular);细胞增殖(Cell Proliferation);DNA甲基化(DNA Methylation);DNA结合蛋白质类(DNA-Binding Proteins);双盲法(Double-Blind Method);减量调节(Down-Regulation);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达谱(Gene Expression Profiling);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);癌前状态(Precancerous Conditions);前瞻性研究(Prospective Studies);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质c-ets(Proto-Oncogene Proteins c-ets);降低风险行为(Risk Reduction Behavior);选择性雌激素受体调节剂(Selective Estrogen Receptor Modulators);他莫昔芬(Tamoxifen);转录因子(Transcription Factors);治疗结果(Treatment Outcome)
DOI
10.1158/1940-6207.CAPR-11-0186
PMID
21778330
发布时间
2024-06-15
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文